Search Results

Below are the search engine results of your query.

Showing 981-990 of 3078 results

Chemours Announces Settlement Agreement with State of Ohio

Agreement resolves the State’s multiple PFAS-related claims. The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announces that it, along with DuPont de Nemours, Inc.

Chemours’ Corpus Christi Site Establishes ChemFEST Partnership with Ingleside Independent School District

The ChemFEST school partnership program is a company-wide effort designed to champion change toward a more diverse science, technology, engineering, and math (STEM) workforce.

Chemours Establishes International F-gas Lifecycle Program to Advance Global Circularity

Reinforces company’s commitment to minimizing environmental impact through resource efficiency The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the creation of an international F-gas Lifecycle Program across the Americas, Asia, and...

To Meet Growing Customer Needs for Thermal Management Solutions, Chemours Announces at the 2023 AHR Expo Its Intention to Bring Next Generation Refrigerants to Market for Qualification in 2025

As a leader in thermal management innovation for more than 90 years, Chemours provides a roadmap for meeting today’s needs and tomorrow’s opportunities with new product development.

Chemours Appoints Brandon Ontjes to Lead Investor Relations Team

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Brandon Ontjes as Vice President, Financial Planning & Analysis (“FP&A”) and Investor Relations.

Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, announced it completed the sale of its Glycolic Acid Business to PureTech Scientific, LLC, a company founded and backed by Iron Path Capital, a private equity firm focused on lower-middle market inv...

Chemical Industry Announces Collaborative Equity, Diversity & Inclusion STEM Scholars Initiative

The American Chemistry Council (ACC), American Institute of Chemical Engineers (AIChE), The Chemours Company and HBCU Week Foundation today announced the chemical industry's first collaborative equity, diversity and inclusion initiative aimed at creating pathways for more underrepresented groups to enter and succeed in the chemical industry.

Chemours Announces Third Quarter Dividend

The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the third quarter of 2020.

The Chemours Company Announces Completion of Private Offering of $800 Million Aggregate Principal Amount of 5.750% Senior Unsecured Notes Due 2028

The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced it had completed its previously announced private offering (the "offering") of $800 million in aggregate principal amount of 5.750% senior unsecured notes due 2028 that was exempt from the registration requirements o...

U.S. Environmental Protection Agency Approves Glyclean™ Hard Surface Cleaner as an Effective Disinfectant Against the Virus that Causes COVID-19

Hard surface disinfectant formulations with Glyclean™AM as the active ingredient effectively kill SARS-CoV-2, the virus that causes COVID-19.